These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 21397779)

  • 21. Understanding dual enrollees' use of Medicare home health services: the effects of differences in Medicaid home care programs.
    Kenney G; Rajan S
    Med Care; 2000 Jan; 38(1):90-8. PubMed ID: 10630723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "Impact of drug-reimbursement policies on prescribing: A case-study of a newly marketed long-acting injectable antipsychotic among relapsed schizophrenia patients".
    Jackson JW; Fulchino L; Rogers J; Mogun H; Polinski J; Henderson DC; Schneeweiss S; Fischer MA
    Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):95-104. PubMed ID: 29168261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistence of use of lipid-lowering medications: a cross-national study.
    Avorn J; Monette J; Lacour A; Bohn RL; Monane M; Mogun H; LeLorier J
    JAMA; 1998 May; 279(18):1458-62. PubMed ID: 9600480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AMCP Guide to Pharmaceutical Payment Methods, 2009 Update (Version 2.0).
    Academy of Managed Care Pharmacy
    J Manag Care Pharm; 2009 Aug; 15(6 Suppl A):S3-57, quiz S58-61. PubMed ID: 19678720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Removal of prior authorization for medication-assisted treatment: impact on opioid use and policy implications in a Medicare Advantage population.
    Ferries E; Racsa P; Bizzell B; Rhodes C; Suehs B
    J Manag Care Spec Pharm; 2021 May; 27(5):596-606. PubMed ID: 33908274
    [No Abstract]   [Full Text] [Related]  

  • 26. Multiple drug cost containment policies in Michigan's Medicaid program saved money overall, although some increased costs.
    Kibicho J; Pinkerton SD
    Health Aff (Millwood); 2012 Apr; 31(4):816-26. PubMed ID: 22492899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Transitioning to Medicare Part D on Access to Drugs for Medical Conditions among Dual Enrollees with Cancer.
    Adams AS; Madden JM; Zhang F; Lu CY; Ross-Degnan D; Lee A; Soumerai SB; Gilden D; Chawla N; Griggs JJ
    Value Health; 2017 Dec; 20(10):1345-1354. PubMed ID: 29241894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of monthly prescription cap on medication persistence among patients with hypertension, hyperlipidemia, or diabetes.
    Wang CC; Wei D; Farley JF
    J Manag Care Pharm; 2013 Apr; 19(3):258-68. PubMed ID: 23537460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adoption of retrospective Medicare maximization billing practices by state Medicaid home care programs.
    Anderson WL; Kenney GS; Rabiner DJ
    J Health Polit Policy Law; 2003 Oct; 28(5):859-81. PubMed ID: 14604215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy: Payer Approvals and Rejections, and Patient Characteristics for Successful Prescribing.
    Hess GP; Natarajan P; Faridi KF; Fievitz A; Valsdottir L; Yeh RW
    Circulation; 2017 Dec; 136(23):2210-2219. PubMed ID: 29084735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. State Policies Influence Medicare Telemedicine Utilization.
    Neufeld JD; Doarn CR; Aly R
    Telemed J E Health; 2016 Jan; 22(1):70-4. PubMed ID: 26218148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of U.S. federal and state generic drug policies on drug use, spending, and patient outcomes: A systematic review.
    Mishuk AU; Fasina I; Qian J
    Res Social Adm Pharm; 2020 Jun; 16(6):736-745. PubMed ID: 31445986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of relaxing hepatitis C treatment restrictions on direct-acting antiviral use in a Medicaid program: an interrupted time series analysis.
    Herink MC; Geddes J; Vo K; Zaman A; Hartung DM
    J Manag Care Spec Pharm; 2021 Jul; 27(7):856-864. PubMed ID: 34185560
    [No Abstract]   [Full Text] [Related]  

  • 34. Medicaid prescription limits: policy trends and comparative impact on utilization.
    Lieberman DA; Polinski JM; Choudhry NK; Avorn J; Fischer MA
    BMC Health Serv Res; 2016 Jan; 16():15. PubMed ID: 26772962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of insurance status on use of recombinant erythropoietin therapy among end-stage renal disease patients in three states.
    Thamer M; Richard C; Ray NF; Greer JW; Cotter DJ; Pearson BC
    Am J Kidney Dis; 1996 Aug; 28(2):235-49. PubMed ID: 8768919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of a limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia.
    Soumerai SB; McLaughlin TJ; Ross-Degnan D; Casteris CS; Bollini P
    N Engl J Med; 1994 Sep; 331(10):650-5. PubMed ID: 8052275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second-Generation Antipsychotic Prescribing Patterns for Pediatric Patients Enrolled in West Virginia Medicaid.
    Melvin KE; Hart JC; Sorvig RD
    Psychiatr Serv; 2017 Oct; 68(10):1061-1067. PubMed ID: 28566023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medicaid prior authorization and opioid medication abuse and overdose.
    Cochran G; Gordon AJ; Gellad WF; Chang CH; Lo-Ciganic WH; Lobo C; Cole E; Frazier W; Zheng P; Kelley D; Donohue JM
    Am J Manag Care; 2017 May; 23(5):e164-e171. PubMed ID: 28810127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Buprenorphine Use Trends Following Removal of Prior Authorization Policies for the Treatment of Opioid Use Disorder in 2 State Medicaid Programs.
    Keshwani S; Maguire M; Goodin A; Lo-Ciganic WH; Wilson DL; Hincapie-Castillo JM
    JAMA Health Forum; 2022 Jun; 3(6):e221757. PubMed ID: 35977240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can restrictions on reimbursement for anti-ulcer drugs decrease Medicaid pharmacy costs without increasing hospitalizations?
    Cromwell DM; Bass EB; Steinberg EP; Yasui Y; Ravich WJ; Hendrix TR; McLeod SF; Moore RD
    Health Serv Res; 1999 Feb; 33(6):1593-610. PubMed ID: 10029499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.